NanoVibronix receives approval for wound healing kit in Canada
Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap
Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future
Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch
Perspectives from China: Chinese M&A in 2022
NanoVibronix Inc. secured regulatory approval to commercialize its WoundShield device in Canada.
The device facilitates soft tissue regeneration and wound healing by using ultrasound. It is already approved in Europe and NanoVibronix plans to pursue regulatory approval in the U.S.